SCHEMBL21136819

SCHEMBL21136819

CNc1cnc2cc(-c3c(O)cccc3F)c(Cl)c(F)c2c1N1CCNCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KRAS P01116 8/20 0.36
NTRK1 P04629 1/20 0.35
KDM4E B2RXH2 1/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
PIM1 P11309 2/20 0.33
PIM2 Q9P1W9 2/20 0.33
PIM3 Q86V86 1/20 0.33
HDAC3 O15379 3/20 0.33
WEE1 P30291 1/20 0.33
HDAC2 Q92769 1/20 0.32
CCNT1 O60563 1/20 0.31
CDK1 P06493 1/20 0.31
CCNB1 P14635 1/20 0.31
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31
CDK7 P50613 1/20 0.31
CDK9 P50750 1/20 0.31
CCNH P51946 1/20 0.31
CCNA1 P78396 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136739 0.85 KRAS (0.49) KRASNTRK1HSP90AA1HSP90AB1PIM1
SCHEMBL21136914 0.76 KDM4E (0.40) KRASNTRK1KDM4EPIM1PIM2
SCHEMBL21050731 0.74 KRAS (0.55) KRASNTRK1
SCHEMBL21137054 0.72 KRAS (0.49) KRASHSP90AA1HSP90AB1WEE1
SCHEMBL21136743 0.70 KRAS (0.65) KRAS
SCHEMBL21136719 0.69 KRAS (0.49) KRASWEE1
SCHEMBL21137067 0.69 KRAS (0.51) KRAS
SCHEMBL21136814 0.68 KRAS (0.37) KRASNTRK1PIM1PIM2PIM3
SCHEMBL21050645 0.68 KRAS (0.55) KRASNTRK1
SCHEMBL21050829 0.67 KRAS (0.51) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed